TickerFacts.

Exagen Inc. (XGN): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$38.80M
Year ended 2025-12-31
$41.70M
Trailing 12 months to 2026-06-30
+22.0%
3-year compound annual growth
+8.8%
5-year compound annual growth
2018-12-31: $17.06M2019-12-31: $21.58M2020-12-31: $25.42M2021-12-31: $27.71M2022-12-31: $21.35M2023-12-31: $29.46M2024-12-31: $33.11M2025-12-31: $38.80M$38.80M
2018-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$38.80M+17.2%2026-03-10, From 2025-01-01
2024-12-31$33.11M+12.4%2026-03-10, From 2024-01-01
2023-12-31$29.46M+38.0%2025-03-11, From 2023-01-01
2022-12-31$21.35M-23.0%2024-03-18, From 2022-01-01
2021-12-31$27.71M+9.0%2023-03-20, From 2021-01-01
2020-12-31$25.42M+17.8%2022-03-22, From 2020-01-01
2019-12-31$21.58M+26.5%2021-03-16, From 2019-01-01
2018-12-31$17.06Mn/a2020-03-25, From 2018-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Exagen Inc. (XGN)2025-12-31$38.80M+17.2%
Personalis, Inc. (PSNL)2025-12-31$15.78M-41.2%
American Shared Hospital Services (AMS)2025-12-31$5.06M-44.9%
BillionToOne, Inc. (BLLN)2025-12-31$208.46M+157.6%
Fulgent Genetics, Inc. (FLGT)2025-12-31$130.88M+22.1%
Castle Biosciences Inc (CSTL)2025-12-31$273.20M+0.5%
Veracyte, Inc. (VCYT)2025-12-31$362.53M+21.6%
BioNexus Gene Lab Corp (BGLC)2025-12-31$1.09M-15.8%
Guardant Health, Inc. (GH)2025-12-31$633.01M+40.9%

Compare XGN, PSNL, AMS, BLLN side by side · Screen every company in Services-Medical Laboratories ↗